Zalunfiban

DB18766InvestigationalSmall molecule

Zalunfiban: Overview.

Mechanism: Pharmacologically active on Integrin alpha-IIb and Integrin beta-3
Curator reviewed
Formula / weight: C₁₆H₁₈N₈O₂S · 386.43 g/mol (avg)
Code names: RUC-4

Resolves to

Compound

Structure

InChIKeyLTVKZVGAALCRFW-UHFFFAOYSA-NSMILESNCC(=O)NC1=CN=CC(=C1)C1=NN2C(S1)=NC(=CC2=O)N1CCNCC1

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

14+ReferencesStructured and connected to the statements they support

Which drugs share a target with Zalunfiban, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.